Pyoderma gangrenosum (PG) may be associated with inflammatory disorders and haematological conditions such as monoclonal gammopathy of uncertain significance (MGUS). We report the case of a 53-year old man who had PG and MGUS. After treatment with infliximab for the PG, he developed myeloma. The course of events in this case suggests that infliximab facilitated the progression from MGUS to myeloma.
Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum is a post from: Skincare
Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum is a post from: Skincare
Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum via BuzzBlazer.com
No comments:
Post a Comment